Quick Answer
Pomegranate Sleep Latency Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: [] established that probiotics must have “defined contents, an adequate number of viable organisms at the end of the shelf life, adequate evidence of health benefits,” and that all probiotics must be “safe for their intended use.” This definition was then confirmed in 2017 by the International Scientific Association for Probiotics and Prebiotics (ISAPP) in an official statement [,].
Key Takeaways
- 01[] established that probiotics must have “defined contents, an adequate number of viable organisms at the end of the shelf life, adequate evidence of health benefits,” and that all probiotics must be “safe for their intended use.” This definition was then confirmed in 2017 by the International Scientific Association for Probiotics and Prebiotics (ISAPP) in an official statement [,]. [Chong Shin-Yee (2026)]
- 02The regulatory classification of probiotics, however, is not uniform and may vary depending on their intended use, formulation, route of administration, and associated health claims. [Chong Shin-Yee (2026)]
- 03In this context, probiotics have been associated with the prevention and management of Non-communicable diseases (NCDs) and Major depressive disorder (MDD) [,,,]. [Chong Shin-Yee (2026)]
- 041 2 3 4 5 6 7 8 9 9 Probiotics are defined as “live microorganisms that, when administered in adequate amounts, confer health benefits on the host” [,]. [Chong Shin-Yee (2026)]
The current Migaku evidence database contains 2 reusable source documents for Pomegranate Sleep Latency Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- [] established that probiotics must have “defined contents, an adequate number of viable organisms at the end of the shelf life, adequate evidence of health benefits,” and that all probiotics must be “safe for their intended use.” This definition was then confirmed in 2017 by the International Scientific Association for Probiotics and Prebiotics (ISAPP) in an official statement [,]. [Chong Shin-Yee (2026); evidence level 3]
- The regulatory classification of probiotics, however, is not uniform and may vary depending on their intended use, formulation, route of administration, and associated health claims. [Chong Shin-Yee (2026); evidence level 3]
- In this context, probiotics have been associated with the prevention and management of Non-communicable diseases (NCDs) and Major depressive disorder (MDD) [,,,]. [Chong Shin-Yee (2026); evidence level 3]
- 1 2 3 4 5 6 7 8 9 9 Probiotics are defined as “live microorganisms that, when administered in adequate amounts, confer health benefits on the host” [,]. [Chong Shin-Yee (2026); evidence level 3]
- Another goal is to consolidate current evidence on the gut–brain axis and its role in neurodegenerative diseases. [Tabaza Raghad (2025); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources